GENELUX Corp

Ownership Transactions Reported by 16 Insiders

Symbol
GNLX on Nasdaq
Location
2625 Townsgate Road, Suite 230, Westlake Village, CA

Insiders trading volume in the past year

GENELUX Corp executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Qian Zhang Associate VP, Research $1.98M Feb 17, 2023
Aladar Szalay 10%+ Owner $1.55M -$2.02M -56.6% Sep 12, 2024
John Thomas Director $1.07M Aug 1, 2024
Thomas Zindrick President and CEO, Director $402K -$33.5K -7.69% Dec 18, 2024
Lourie S. Zak Chief Financial Officer $193K -$4.92K -2.49% Dec 18, 2024
Gabe Woodward Director $175K Feb 17, 2023
James L. Tyree Director $126K Sep 11, 2024
John W. Smither Director $112K Aug 1, 2024
Mary Mirabelli Director $110K Aug 1, 2024
Joseph Cappello VP, Pharmaceutical Development $102K -$14.7K -12.6% Dec 18, 2024
Sean Ryder General Counsel $96.8K -$11.7K -10.7% Dec 18, 2024
Yong Yu VP, Clinical Trial Operations $93.3K -$14.5K -13.5% Dec 18, 2024
Ralph Smalling Head of Regulatory $74.5K -$5.87K -7.31% Dec 18, 2024
Caroline Jewett Head of Quality $34.3K -$10.5K -23.5% Feb 19, 2024
Doug Samuelson Vice President, Finance Sep 11, 2023
Paul Scigalla Chief Medical Officer Oct 18, 2024

Recent Insider Transactions by Companies or Individuals for GENELUX Corp

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.